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(CTV) delineation for postoperative gastric cancer (GC). The 
effect of a dedicated training course on interobserver 
variability in the CTV delineation among residents in 
radiation oncology was evaluated. 
Materials and Methods: Twenty residents from several 
institutions delineated the CTV for the same case of 
postoperative GC before and after a training course on target 
volume definition. CTV was delineated on four planning 
computed tomography (CT) scans: the dome of the 
diaphragm, the anterior abdominal wall, the duodenal stump 
and the porta hepatis level. Participants were also asked to 
determine the most caudal scan of the CTV. The rough 
volume of the CTV for each participant was reconstructed 
from all requested planar contours. The reference contours 
were proposed by the senior radiation oncologist. Area of 
Intersection (AI) and Volume of Intersection (VI), defined as 
the overlap of delineated area/volume with respective 
reference area (RA)/ reference volume (RV), were computed 
using dedicated software for each participant. AI was 
calculated for each requested CT scan. The degree of 
agreement between the reference contours and participants’ 
delineations was quantified using the Concordance Index (CI) 
for respective areas and volumes, defined as the percent 
ratio of the AI or VI to the RA or RV (AI/RA•100% or 
VI/RV•100%). Additional analysis of the lower CTV border 
(distance from the reference level) was performed. The CIs 
for areas and volumes obtained before and after the course 
were compared using the Student t-test. A questionnaire was 
developed to gather data regarding the difficulties the 
participants faced during the CTV delineation before and 
after the course. 
Results: The mean value of CI for all participants was the 
lowest for the dome of the diaphragm and for the duodenal 
stump (24% and 49% before the course, 35% and 61% after the 
course, respectively). The highest mean CI was recorded for 
the abdominal wall (73% before and 83% after the course). 
For all delineated CT scans, CI was higher after than before 
the course, although the differences were not statistically 
significant. Mean CI for the CTV volume was 49% before and 
59% after the course, respectively, p = 0.17. The mean 
distance from the reference to the participants' lower CTV 
borders was 2.73 cm before and 2.0 cm after the course, 
respectively, p = 0.17. In a questionnaire, 75% of respondent 
indicated the elective nodal area as the main difficulty when 
contouring the CTV, particularly with regard to para-aortic, 
mesenteric and porta hepatis lymph nodes. 
Conclusions: Elective nodal area is the main subjective 
difficulty faced in CTV delineation for postoperative GC, 
however the largest interobserver variability was shown for 
the dome of the diaphragm. The differences tended to 
decrease after the course.  
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Purpose/Objective: Conventional dark ink tattoos used for 
external references during breast radiotherapy can negatively 
impact patients' long term cosmetic outcomes, serve as a 
reminder of their diagnosis and treatment and be incorrectly 
identified in patients with dark skin tone. Fluorescent tattoos 
offer an innovative solution to overcome these limitations 
but have not previously been clinically tested. This study 
evaluates the efficacy of using fluorescent tattoos together 
with the impact on patient experience in those undergoing 
breast radiotherapy. The primary endpoint was inter-fraction 
reproducibility (population random error) determined using 
electronic portal imaging (EPI). 
Materials and Methods: Prior to recruitment, extensive pilot 
work was performed to assess visibility of fluorescent inks 
with a selection of UV torches. Forty six patients receiving 
adjuvant radiotherapy for BC were randomised to receive 
either fluorescent (n=24) or conventional dark-ink tattoos 
(n=22). Tattoos were administered bilaterally and midline. 
EPI data was used to determine setup accuracy and compared 
between groups using a one sided t-test. Timing data was 
recorded at CT planning and treatment sessions to identify 
resource requirements. A validated body image scale (BIS) 
was completed at baseline (pre-treatment), 1 month and 6 
months post planning scan to determine the impact of tattoo 
type on body image. 
Results: Pilot work demonstrated that optimum torch and 
fluorescent ink selection was paramount for safe and 
effective application of this method. No adverse effects were 
reported and fluorescent tattoos were visible in 22 of 24 
patients. Fluorescent tattoos could not be sufficiently 
visualised in two patients with sub-Saharan skin tone and 
they were re-tattooed with conventional dark ink. Random 
displacements for the fluorescent tattoo group were less than 
2.8mm in the anterior-posterior and cranio-caudal directions 
(p= 0.001; p=0.009 respectively). There were no statistically 
significant differences in random and systematic errors 
between the two groups. There was a modest increase in 
setup time (mean=1.4mins) associated with fluorescent 
tattoos. BIS scores were worse at 1 month in 50% of patients 
with dark ink tattoos compared to only 24% of patients with 
fluorescent tattoos (six month results available 2015).  
Conclusions: The use of external reference fluorescent 
tattoos with optimum UV torches is an innovative alternative 
to using conventional dark ink for breast radiotherapy. EPI 
data suggests there is no significant difference in inter-
fraction reproducibility. Analysis of body image data suggests 
that, for a proportion of breast radiotherapy patients, use of 
fluorescent tattoos can improve patient experience and 
enhance survivorship. 
  
 
